RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Use and misuse of GLP-1 receptor agonists among people with eating disorders
Peiper, N. C., Zibbell, J. E., LaJoie, A. S., Wahlang, B., Krishnasamy, S. S., & Levinson, C. A. (2026). Use and misuse of GLP-1 receptor agonists among people with eating disorders. JAMA Psychiatry . Advance online publication. https://doi.org/10.1001/jamapsychiatry.2026.1716
This cross-sectional study evaluates the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and misuse among people with eating disorders in the US.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.